These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34145182)

  • 21. Antidepressant treatment for posttraumatic stress disorder (PTSD).
    Harris SE
    J Clin Psychiatry; 1986 May; 47(5):275. PubMed ID: 3700349
    [No Abstract]   [Full Text] [Related]  

  • 22. Cost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome.
    Christensen MC; Munro V
    Curr Med Res Opin; 2018 Apr; 34(4):593-600. PubMed ID: 29235884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmenting Computerized Cognitive Training With Vortioxetine for Age-Related Cognitive Decline: A Randomized Controlled Trial.
    Lenze EJ; Stevens A; Waring JD; Pham VT; Haddad R; Shimony J; Miller JP; Bowie CR
    Am J Psychiatry; 2020 Jun; 177(6):548-555. PubMed ID: 32212856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder.
    Jain R; Mahableshwarkar AR; Jacobsen PL; Chen Y; Thase ME
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):313-21. PubMed ID: 22963932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive Improvements with Vortioxetine in Schizophrenia: A Case Report.
    Biswas T; Mishra BR; Ranjan R; Maiti R
    Psychiatr Danub; 2022; 34(4):731-732. PubMed ID: 36548892
    [No Abstract]   [Full Text] [Related]  

  • 26. Paroxetine, but not Vortioxetine, Impairs Sexual Functioning Compared With Placebo in Healthy Adults: A Randomized, Controlled Trial.
    Jacobsen P; Zhong W; Nomikos G; Clayton A
    J Sex Med; 2019 Oct; 16(10):1638-1649. PubMed ID: 31405765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vortioxetine on Cognition in Schizophrenia: A Pilot Study.
    Bruno A; Zoccali RA; Troili GM; Scala L; Pandolfo G; Cedro C; Mento C; Santoro V; Spina E; Muscatello MRA
    J Clin Psychopharmacol; 2020; 40(4):381-385. PubMed ID: 32639291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Placebo effect in posttraumatic stress disorders.
    Krakow B; Hollifield M; Warner TD
    JAMA; 2000 Aug; 284(5):563-4. PubMed ID: 10918693
    [No Abstract]   [Full Text] [Related]  

  • 29. Results of a real-world study on vortioxetine in patients with major depressive disorder in South East Asia (REVIDA).
    Chin CN; Zain A; Hemrungrojn S; Ung EK; Kwansanit P; Au Yong KC; Chong MSW; Inpa C; Yen TH; Yeoh BBD; Tay LK; Bernardo C; Lim LC; Yap CH; Fones C; Nayak A; Nelleman L
    Curr Med Res Opin; 2018 Nov; 34(11):1975-1984. PubMed ID: 29768955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregabalin in the treatment of posttraumatic stress disorder: a case report.
    Paslakis G; Gilles M; Deuschle M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1160-1. PubMed ID: 21338648
    [No Abstract]   [Full Text] [Related]  

  • 31. [Posttraumatic stress disorder in children and adolescents].
    Kekelidze ZI; Portnova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(12):56-61. PubMed ID: 12520783
    [No Abstract]   [Full Text] [Related]  

  • 32. Psychobiological substrates of posttraumatic stress disorder: part II.
    Dowben JS; Grant JS; Keltner NL
    Perspect Psychiatr Care; 2007 Jul; 43(3):146-9. PubMed ID: 17576308
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: A short-term, randomized, double-blind, exploratory study.
    Baune BT; Sluth LB; Olsen CK
    J Affect Disord; 2018 Mar; 229():421-428. PubMed ID: 29331703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment Effects of Vortioxetine on Cognitive Functions in Mild Alzheimer's Disease Patients with Depressive Symptoms: A 12 Month, Open-Label, Observational Study.
    Cumbo E; Cumbo S; Torregrossa S; Migliore D
    J Prev Alzheimers Dis; 2019; 6(3):192-197. PubMed ID: 31062834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram.
    Vieta E; Sluth LB; Olsen CK
    J Affect Disord; 2018 Feb; 227():803-809. PubMed ID: 29673132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paroxetine
    Callegari C; Ielmini M; Caselli I; Lucca G; Isella C; Diurni M; Pettenon F; Poloni N
    Psychopharmacol Bull; 2019 Feb; 49(1):28-43. PubMed ID: 30858637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using self-reported vocational functioning measures to identify employed patients with impaired functional capacity in major depressive disorder.
    Murthy NV; Xu R; Zhong W; Harvey PD
    J Affect Disord; 2020 Jan; 260():550-556. PubMed ID: 31539692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vortioxetine-Induced Amenorrhea: A Case Report.
    Işik M; Kurhan F; Ülkevan T; Özdemir PG
    Clin Neuropharmacol; 2022 Jan-Feb 01; 45(1):7-8. PubMed ID: 35029863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vortioxetine improves cognition in mild cognitive impairment.
    Tan SN; Tan C
    Int Clin Psychopharmacol; 2021 Nov; 36(6):279-287. PubMed ID: 34282748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A preliminary controlled trial of divalproex in posttraumatic stress disorder.
    Hamner MB; Faldowski RA; Robert S; Ulmer HG; Horner MD; Lorberbaum JP
    Ann Clin Psychiatry; 2009; 21(2):89-94. PubMed ID: 19439158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.